Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade

Baraibar-Argota, I. (Iosune)

Authors:

Baraibar-Argota, I. (Iosune)

Directors:

Gil-Bazo, I. (Ignacio)

Keywords:

Materias Investigacion::Ciencias de la Salud::Oncología
Cáncer de pulmón
Lung cancer

Issue Date:

8-Jun-2021

Defense Date:

22-Jun-2021

Publisher:

Universidad de Navarra

Citation:

BARAIBAR ARGOTA, Iosune. “Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade". Gil, I. (dirs.). Tesis doctoral. Universidad de Navarra, Pamplona, 2021.

Abstract

According to the Global Cancer Observatory (http://gco.iarc.fr), primary lung cancer ranks as the most common tumor worldwide and the leading cause of cancer-related mortality. In 2020, 2.2 million new lung cancer cases were diagnosed, which comprises 12.2% of total cancers.

URI:

https://hdl.handle.net/10171/61070

Appears in Collections:

DA - Medicina - Tesis doctorales
Facultad de Medicina - Tesis Doctorales y Tesinas - 2020-2029

Files in This Item: